Lenington Rachel 4
4 · Athira Pharma, Inc. · Filed Jan 23, 2023
Insider Transaction Report
Form 4
Lenington Rachel
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-01-19+200,000→ 200,000 totalExercise: $3.37Exp: 2033-01-18→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]One thirty-sixth (1/36th) of the shares subject to the option will vest on February 19, 2023 and one thirty-sixth of the shares subject to the option will vest each month thereafter.